The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents
Open accessAbstract
Throughout history, natural products have played a dominant role in the treatment of human ailments. For example, the legendary discovery of penicillin transformed global existence. Presently, natural products comprise a large portion of current-day pharmaceutical agents, most notably in the area of cancer therapy. Examples include Taxol, vinblastine, and camptothecin. These structurally unique agents function by novel mechanisms of action; isolation from natural sources is the only plausible method that could have led to their discovery. In addition to terrestrial plants as sources for starting materials, the marine environment (e.g., ecteinascidin 743, halichondrin B, and dolastatins), microbes (e.g., bleomycin, doxorubicin, and staurosporin), and slime molds (e.g., epothilone B) have yielded remarkable cancer chemotherapeutic agents. Irrespective of these advances, cancer remains a leading cause of death worldwide. Undoubtedly, the prevention of human cancer is highly preferable to treatment. Cancer chemoprevention, the use of vaccines or pharmaceutical agents to inhibit, retard, or reverse the process of carcinogenesis, is another important approach for easing this formidable public health burden. Similar to cancer chemotherapeutic agents, natural products play an important role in this field. There are many examples, including dietary phytochemicals such as sulforaphane and phenethyl isothiocyanate (cruciferous vegetables) and resveratrol (grapes and grape products). Overall, natural product research is a powerful approach for discovering biologically active compounds with unique structures and mechanisms of action. Given the unfathomable diversity of nature, it is reasonable to suggest that chemical leads can be generated that are capable of interacting with most or possibly all therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304369 · Cited by 6,712
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Self-citationChimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935
Self-citationNatural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687
Self-citationYang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,253
Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence
Block, G., Patterson, B., & Subar, A. (1992) · Nutrition and Cancer · doi:10.1080/01635589209514201 · Cited by 3,238
Fisher, B., Costantino, J. P., Wickerham, D. L., Cecchini, R. S., Cronin, W. M., Robidoux, A., Bevers, T. B., Kavanah, M. T., Atkins, J. N., Margolese, R. G., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji372 · Cited by 1,339
Impact of Natural Products on Developing New Anti-Cancer Agents
Cragg, G. M., Grothaus, P. G., & Newman, D. J. (2009) · Chemical Reviews · doi:10.1021/cr900019j · Cited by 1,302
Self-citationThe emerging role of the Nrf2–Keap1 signaling pathway in cancer
Jaramillo, M. C., & Zhang, D. D. (2013) · Genes & Development · doi:10.1101/gad.225680.113 · Cited by 1,297
Molecular basis of the Keap1–Nrf2 system
Suzuki, T., & Yamamoto, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.006 · Cited by 995
Rothwell, P. M., Wilson, M., Price, J. F., Belch, J. F., Meade, T. W., & Mehta, Z. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60209-8 · Cited by 984
Deep, diverse and definitely different: Unique attributes of the world’s largest ecosystem
Ramirez-Llodra, E., Brandt, A., Danovaro, R., De Mol, B., Escobar, E., German, C. R., Levin, L. A., Martinez Arbizu, P., Menot, L., Buhl-Mortensen, P., et al. (2010) · Biogeosciences · doi:10.5194/bg-7-2851-2010 · Cited by 913
Albanes, D., Heinonen, O. P., Taylor, P. R., Virtamo, J., Edwards, B. K., Rautalahti, M., Hartman, A. M., Palmgren, J., Freedman, L. S., Haapakoski, J., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.21.1560 · Cited by 901
Recent Advances in Chemoprevention of Cancer
Hong, W. K., & Sporn, M. B. (1997) · Science · doi:10.1126/science.278.5340.1073 · Cited by 827
Natural products for cancer chemotherapy
Demain, A. L., & Vaishnav, P. (2011) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2010.00221.x · Cited by 715
Cronin, K. A., Ries, L. A. G., & Edwards, B. K. (2014) · Cancer · doi:10.1002/cncr.29049 · Cited by 699
Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
Ren, D., Villeneuve, N. F., Jiang, T., Wu, T., Lau, A., Toppin, H. A., & Zhang, D. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014275108 · Cited by 673
Antibody–drug conjugates: targeted drug delivery for cancer
Alley, S. C., Okeley, N. M., & Senter, P. D. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.06.170 · Cited by 656
Surveillance, Epidemiology, and End Results Program
National Cancer Institute (2020) · Definitions · doi:10.32388/5owtl5 · Cited by 626
Anticancer compounds derived from fungal endophytes: their importance and future challenges
Kharwar, R. N., Mishra, A., Gond, S. K., Stierle, A., & Stierle, D. (2011) · Natural Product Reports · doi:10.1039/c1np00008j · Cited by 530
Venoms as a platform for human drugs: translating toxins into therapeutics
King, G. F. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.621940 · Cited by 516
Fischer, T., Stone, R. M., DeAngelo, D. J., Galinsky, I., Estey, E., Lanza, C., Fox, E., Ehninger, G., Feldman, E. J., Schiller, G. J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.9678 · Cited by 504
Ingenol Mebutate Gel for Actinic Keratosis
Lebwohl, M., Swanson, N., Anderson, L. L., Melgaard, A., Xu, Z., & Berman, B. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1111170 · Cited by 471
LoRusso, P. M., Weiss, D., Guardino, E., Girish, S., & Sliwkowski, M. X. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0762 · Cited by 444
Antibody Conjugate Therapeutics: Challenges and Potential
Teicher, B. A., & Chari, R. V. J. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1417 · Cited by 427
Potent antibody drug conjugates for cancer therapy
Senter, P. D. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.03.023 · Cited by 401
Forero, E., & Hartwell, J. L. (1989) · The Bryologist · doi:10.2307/3244038 · Cited by 375
Liposomal paclitaxel formulations
Koudelka, Š., & Turánek, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.006 · Cited by 366
Keap1–Nrf2 Signaling: A Target for Cancer Prevention by Sulforaphane
Kensler, T. W., Egner, P. A., Agyeman, A. S., Visvanathan, K., Groopman, J. D., Chen, J.-G., Chen, T.-Y., Fahey, J. W., & Talalay, P. (2012) · Topics in Current Chemistry · doi:10.1007/128_2012_339 · Cited by 361
Fruit and vegetables and cancer risk
Key, T. J. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606032 · Cited by 339
The pharmacology of resveratrol in animals and humans
Park, E.-J., & Pezzuto, J. M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.01.014 · Cited by 302
Long-Term Survival of Participants in the Prostate Cancer Prevention Trial
Thompson, I. M., Goodman, P. J., Tangen, C. M., Parnes, H. L., Minasian, L. M., Godley, P. A., Lucia, M. S., & Ford, L. G. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215932 · Cited by 288
Microbial genome mining for accelerated natural products discovery: is a renaissance in the making?
Bachmann, B. O., Van Lanen, S. G., & Baltz, R. H. (2014) · Journal of Industrial Microbiology and Biotechnology · doi:10.1007/s10295-013-1389-9 · Cited by 276
Anticancer Agents from Natural Products
(2011) · CRC Press eBooks · doi:10.1201/b11185 · Cited by 256
Diversity, abundance and natural products of marine sponge-associated actinomycetes
Abdelmohsen, U. R., Bayer, K., & Hentschel, U. (2014) · Nat. Prod. Rep. · doi:10.1039/c3np70111e · Cited by 252
Newman, D., & Cragg, G. (2014) · Marine Drugs · doi:10.3390/md12010255 · Cited by 250
Self-citationUpdate on taxane development: new analogs and new formulations
Tkaczuk, K., & Yared, J. (2012) · Drug Design, Development and Therapy · doi:10.2147/dddt.s28997 · Cited by 247
New Horizons for Old Drugs and Drug Leads
Cragg, G. M., Grothaus, P. G., & Newman, D. J. (2014) · Journal of Natural Products · doi:10.1021/np5000796 · Cited by 246
Self-citationWeiss, G. J., Chao, J., Neidhart, J. D., Ramanathan, R. K., Bassett, D., Neidhart, J. A., Choi, C. H. J., Chow, W., Chung, V., Forman, S. J., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-012-9921-8 · Cited by 230
Nature: a vital source of leads for anticancer drug development
Cragg, G. M., & Newman, D. J. (2009) · Phytochemistry Reviews · doi:10.1007/s11101-009-9123-y · Cited by 202
Self-citationProdrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38
Bala, V., Rao, S., Boyd, B. J., & Prestidge, C. A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.022 · Cited by 197
Cancer Chemoprevention and Nutri-Epigenetics: State of the Art and Future Challenges
Gerhauser, C. (2012) · Topics in Current Chemistry · doi:10.1007/128_2012_360 · Cited by 194
BERGMANN, W., & BURKE, D. C. (1955) · The Journal of Organic Chemistry · doi:10.1021/jo01128a007 · Cited by 194
Antibody–drug conjugates—A new wave of cancer drugs
Bouchard, H., Viskov, C., & Garcia-Echeverria, C. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.10.021 · Cited by 190
Antibody–drug conjugates for cancer: poised to deliver?
Hughes, B. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3270 · Cited by 188
Mooney, C. J., Nagaiah, G., Fu, P., Wasman, J. K., Cooney, M. M., Savvides, P. S., Bokar, J. A., Dowlati, A., Wang, D., Agarwala, S. S., et al. (2009) · Thyroid · doi:10.1089/thy.2008.0321 · Cited by 180
The Nrf2-Keap1-ARE Signaling Pathway: The Regulation and Dual Function of Nrf2 in Cancer
Zhang, D. D. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3301 · Cited by 178
From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes
Kim, K. B., & Crews, C. M. (2013) · Natural Product Reports · doi:10.1039/c3np20126k · Cited by 175
Biotechnological applications of psychrophiles
Margesin, R., & Feller, G. (2010) · Environmental Technology · doi:10.1080/09593331003663328 · Cited by 160
Zweifel, M., Jayson, G. C., Reed, N. S., Osborne, R., Hassan, B., Ledermann, J., Shreeves, G., Poupard, L., Lu, S.-P., Balkissoon, J., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq708 · Cited by 159
Bacterial symbionts and natural products
Crawford, J. M., & Clardy, J. (2011) · Chemical Communications · doi:10.1039/c1cc11574j · Cited by 155
Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101
Svenson, S., Wolfgang, M., Hwang, J., Ryan, J. L., & Eliasof, S. D. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.007 · Cited by 153
Sosa, J. A., Elisei, R., Jarząb, B., Balkissoon, J., Lu, S.-P., Bal, C., Marur, S., Gramza, A. W., Ben‐Yosef, R., Gitlitz, B. J., et al. (2013) · Thyroid · doi:10.1089/thy.2013.0078 · Cited by 151
Siller, G., Gebauer, K., Welburn, P., Katsamas, J., & Ogbourne, S. M. (2009) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.2008.00497.x · Cited by 147
The Protective Effect of the Mediterranean Diet: Focus on Cancer and Cardiovascular Risk
Pauwels, E. K. J. (2011) · Medical Principles and Practice · doi:10.1159/000321197 · Cited by 143
Antibody-Drug Conjugate Targets
Teicher, B. A. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909790192365 · Cited by 142
Cancer wars: natural products strike back
Basmadjian, C., Zhao, Q., Bentouhami, E., Djehal, A., Nebigil, C. G., Johnson, R. A., Serova, M., Gramont, A. D. E., Faivre, S. J., Raymond, É., et al. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00020 · Cited by 142
Awada, A. H., Bondarenko, I., Bonneterre, J. M., Nowara, E., Ferrero, J.-M., Bakshi, A. V., Wilke, C., & Piccart, M. J. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu025 · Cited by 142
Treatment of metastatic pancreatic adenocarcinoma: a review.
Thota, R., Pauff, J. M., & Berlin, J. D. (2014) · PubMed · Cited by 128
Metagenomic approaches to natural products from free-living and symbiotic organisms
Brady, S. F., Simmons, L., Kim, J. H., & Schmidt, E. W. (2009) · Natural Product Reports · doi:10.1039/b817078a · Cited by 128
From micrograms to grams: scale-up synthesis of eribulin mesylate
Yu, M. J., Zheng, W., & Seletsky, B. M. (2013) · Natural Product Reports · doi:10.1039/c3np70051h · Cited by 120
Antitumor Activity of Bruceantin: An Old Drug with New Promise,
Cuendet, M., & Pezzuto, J. M. (2003) · Journal of Natural Products · doi:10.1021/np030304+ · Cited by 117
Self-citationNab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review
Montero, A. J., Adams, B., Diaz-Montero, C. M., & Glück, S. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.7 · Cited by 95
Slingerland, M., Guchelaar, H., Rosing, H., Scheulen, M. E., van Warmerdam, L. J. C., Beijnen, J. H., & Gelderblom, H. A. J. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.10.009 · Cited by 89
Design of next-generation protein therapeutics
Caravella, J. A., & Lugovskoy, A. A. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.06.175 · Cited by 87
Metagenomic small molecule discovery methods
Charlop–Powers, Z., Milshteyn, A., & Brady, S. F. (2014) · Current Opinion in Microbiology · doi:10.1016/j.mib.2014.05.021 · Cited by 85
Bacterial symbionts in agricultural systems provide a strategic source for antibiotic discovery
Ramadhar, T. R., Beemelmanns, C., Currie, C. R., & Clardy, J. (2013) · The Journal of Antibiotics · doi:10.1038/ja.2013.77 · Cited by 85
Mata‐Greenwood, E., Cuendet, M., Sher, D., Gustin, D. M., Stock, W., & Pezzuto, J. (2002) · Leukemia · doi:10.1038/sj.leu.2402696 · Cited by 83
Self-citationDy, G. K., Gupta, N., & Hatoum, H. A. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s41770 · Cited by 81
The failure of cancer chemoprevention
Potter, J. D. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu063 · Cited by 79
Potts, B. C. M., & Lam, K. S. (2010) · Marine Drugs · doi:10.3390/md8040835 · Cited by 73
Five-Year Analysis of the Prevention of Colorectal Sporadic Adenomatous Polyps Trial
Arber, N., Špičák, J., Rácz, I. A., Zavoral, M., Breazna, A., Gerletti, P., Lechuga, M. J., Collins, N. T., Rosenstein, R. B., Eagle, C. J., et al. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.116 · Cited by 70
Thompson, J. L. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1r561 · Cited by 68
Fang, F. G., Austad, B. C., Calkins, T. L., Chase, C. E., Horstmann, T., Hu, Y., Lewis, B. M., Niu, X., Noland, T. A., Orr, J. D., et al. (2013) · Synlett · doi:10.1055/s-0032-1318026 · Cited by 67
Paclitaxel poliglumex for ovarian cancer
Galic, V., Wright, J. D., Lewin, S. N., & Herzog, T. J. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.576666 · Cited by 60
Barginear, M. F., John, V. S., & Budman, D. R. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00302 · Cited by 59
Villanueva, C., Bazán, F., Kim, S. C. H., Demarchi, M., Chaigneau, L., Thiery-Vuillemin, A., Nguyen, T., Cals, L., Dobi, E., & Pivot, X. B. (2011) · Drugs · doi:10.2165/11591390-000000000-00000 · Cited by 59
Screening and Expression of Genes from Metagenomes
Leis, B., Angelov, A., & Liebl, W. (2013) · Advances in applied microbiology · doi:10.1016/b978-0-12-407678-5.00001-5 · Cited by 58
Caspase-1 Inhibitors from an Extremophilic Fungus That Target Specific Leukemia Cell Lines
Stierle, A. A., Stierle, D. B., & Girtsman, T. (2012) · Journal of Natural Products · doi:10.1021/np200414c · Cited by 52
Risk-Benefit Profiles of Women Using Tamoxifen for Chemoprevention
Nichols, H. B., DeRoo, L. A., Scharf, D. R., & Sandler, D. P. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju354 · Cited by 49
Bulitta, J. B., Zhao, P., Arnold, R. D., Kessler, D. R., Daifuku, R., Pratt, J., Luciano, G., Hanauske, A.-R., Gelderblom, H., Awada, A., et al. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0827-2 · Cited by 47
Kingston, D. G. I. (2005) · CRC Press eBooks · doi:10.1201/9781420039658.ch6 · Cited by 47
Strieth, S., Dunau, C., Michaelis, U., Jäger, L., Gellrich, D., Wollenberg, B., & Dellian, M. (2013) · Head & Neck · doi:10.1002/hed.23397 · Cited by 46
Walsh, M. D., Hanna, S. K., Sen, J. M., Rawal, S., Cabral, C. B., Yurkovetskiy, A., Fram, R. J., Lowinger, T. B., & Zamboni, W. C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1554 · Cited by 46
Carfilzomib: A new proteasome inhibitor for relapsed or refractory multiple myeloma
Steele, J. M. (2013) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155212470388 · Cited by 44
Carfilzomib: a novel agent for multiple myeloma
Redic, K. A. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12072 · Cited by 40
Characterization of Natural Product Chemopreventive Agents
Pezzuto, J. M., Kosmeder, J. W., Park, E., Lee, S. K., Cuendet, M., Gills, J. J., Bhat, K., Grubjesic, S., Park, H.-S., Mata‐Greenwood, E., et al. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-768-0_1 · Cited by 38
Self-citationDiscovery of E7389, a Fully Synthetic Macrocyclic Ketone Analog of Halichondrin B
Yu, M. J., Littlefield, B. A., & Kishi, Y. (2005) · CRC Press eBooks · doi:10.1201/9781420039658.ch13 · Cited by 38
Thigpen, J. T. (2012) · Yearbook of Medicine · doi:10.1016/s0084-3873(12)00190-3 · Cited by 37
The Discovery and Development of the Combretastatins
Cragg, G. M., Kingston, D. G. I., & Newman, D. J. (2011) · CRC Press eBooks · doi:10.1201/b11185-7 · Cited by 37
Self-citationMuggia, F. M., & Kudlowitz, D. (2013) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000053 · Cited by 34
Ingenol mebutate: A new option for actinic keratosis treatment
Gras, J. (2013) · Drugs of today · doi:10.1358/dot.2013.49.1.1910723 · Cited by 32
The Dolastatins: Novel Antitumor Agents from Dolabella auricularia
Flahive, E. J., & Srirangam, J. K. (2005) · CRC Press eBooks · doi:10.1201/9781420039658.ch11 · Cited by 29
Omacetaxine mepesuccinate in the treatment of intractable chronic myeloid leukemia
Li, S., & Chen, Y. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s41786 · Cited by 28
Bulitta, J. B., Zhao, P., Arnold, R. D., Kessler, D. R., Daifuku, R., Pratt, J., Luciano, G., Hanauske, A., Gelderblom, H. A. J., Awada, A. H., et al. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0828-1 · Cited by 25
Shea, J., Nam, K.-H., Rapoport, N. Y., & Scaife, C. L. (2011) · HPB · doi:10.1111/j.1477-2574.2010.00249.x · Cited by 22
Clofarabine in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Older Adults
Tran, H., & Yang, D. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1q295 · Cited by 16
Turner, D., González, A., Pettiford, L. C., Meacham, A. M., Wise, E. A., Bosse, R. C., Chaplin, D. J., Hsu, J. W., Brown, R. A., Hiemenz, J. W., et al. (2013) · Blood · doi:10.1182/blood.v122.21.1463.1463 · Cited by 12
Jamieson, K. J., & Lim, M. Y. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s39558 · Cited by 11
Trastuzumab emtansine, tumor-activated prodrug (TAP) immunoconjungate, oncolytic
Kümler, I., Mortensen, C. E., & Nielsen, D. (2011) · Drugs of the Future · doi:10.1358/dof.2011.036.11.1711891 · Cited by 8
Natural Product Cytotoxins as Payloads for Antibody Drug Conjugates
Koehn, F. E. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4654-5_5 · Cited by 7
Marine Organisms in Cancer Chemoprevention
Park, E.-J., Shaikh, A., Murphy, B. T., & Pezzuto, J. M. (2015) · CRC Press eBooks · doi:10.1201/b19081-14 · Cited by 4
Self-citation
Cited by
Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy
Dehelean, C. A., Marcovici, I., Soica, C., Mioc, M., Coricovac, D., Iurciuc, S., Cretu, O. M., & Pinzaru, I. (2021) · Molecules · doi:10.3390/molecules26041109 · Cited by 502
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
Kashyap, D., Tuli, H. S., Yerer, M. B., Sharma, A., Sak, K., Srivastava, S., Pandey, A., Garg, V. K., Sethi, G., & Bishayee, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.014 · Cited by 390
Chunarkar-Patil, P., Kaleem, M., Mishra, R., Ray, S., Ahmad, A., Verma, D., Bhayye, S., Dubey, R., Singh, H., & Kumar, S. (2024) · Biomedicines · doi:10.3390/biomedicines12010201 · Cited by 390
The Role of Polyphenol (Flavonoids) Compounds in the Treatment of Cancer Cells
Hazafa, A., Rehman, K.-U., Jahan, N., & Jabeen, Z. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2019.1637006 · Cited by 388
Isothiocyanates: An Overview of Their Antimicrobial Activity against Human Infections
Romeo, L., Iori, R., Rollin, P., Bramanti, P., & Mazzon, E. (2018) · Molecules · doi:10.3390/molecules23030624 · Cited by 230
Metadata
- Authors
- Cragg, G. M., & Pezzuto, J. M.
- Venue
- Medical Principles and Practice
- Publisher
- S. Karger AG
- Published
- 2015-12-17
- Volume
- 25
- Issue
- Suppl. 2
- Pages
- 41-59
- ISSN
- 1011-7571 (ISSN-L)
- 1423-0151
- OpenAlex
- W2214273798
- Cited by
- 798
- References
- 103
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.